Zeitschriftenaufsatz | 2019

A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1^T315I in Ph+ CML.

Autor:in

Gleixner, Karoline V; Sadovnik, Irina; Schneeweiss, Mathias; Eisenwort, Gregor; Byrgazov, Konstantin; Stefanzl, Gabriele; Berger, Daniela; Herrmann, Harald; Hadzijusufovic, Emir; Lion, Thomas; Valent, Peter

Publikationen als Autor:in / Herausgeber:in der Vetmeduni

Hadzijusufovic, Emir

Journal

Leukemia Research

Schlagwörter

Aniline Compoundspharmacology; Antineoplastic Combined Chemotherapy Protocolspharmacology; Apoptosisdrug effects; Cell Line, Tumor; Dasatinibpharmacology; Drug Resistance, Neoplasmdrug effectsgenetics; Drug Synergism; Fusion Proteins, bcr-ablgenetics; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positivegenetics; Nitrilespharmacology; Quinolinespharmacology

Dokumententyp

Originalarbeit

ISSN/eISSN

0145-2126 -

DOI

10.1016/j.leukres.2018.12.013

WoS ID

WOS:000458160400008

PubMed ID

30711891